These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 28339030)
21. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer. Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. Yu MH; Luo Y; Qin SL; Zhong M Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586 [TBL] [Abstract][Full Text] [Related]
23. The clinical significance of forkhead box protein A1 and its role in colorectal cancer. Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093 [TBL] [Abstract][Full Text] [Related]
24. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer. Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443 [TBL] [Abstract][Full Text] [Related]
25. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer. Xu Z; Wang H; Gao L; Zhang H; Wang X Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer. Zeng J; Tang ZH; Liu S; Guo SS World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma. Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312 [TBL] [Abstract][Full Text] [Related]
28. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma. Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042 [TBL] [Abstract][Full Text] [Related]
29. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
30. High SHIP2 expression indicates poor survival in colorectal cancer. Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X Dis Markers; 2014; 2014():218968. PubMed ID: 25525286 [TBL] [Abstract][Full Text] [Related]
31. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer. Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197 [TBL] [Abstract][Full Text] [Related]
32. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer. Ohrling K; Edler D; Hallström M; Ragnhammar P Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy. Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492 [TBL] [Abstract][Full Text] [Related]
34. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Park HS; Kim BC; Yeo HY; Kim KH; Yoo BC; Park JW; Chang HJ Oncol Rep; 2018 May; 39(5):2279-2287. PubMed ID: 29498404 [TBL] [Abstract][Full Text] [Related]
35. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer. Hong KD; Lee Y; Kim BH; Lee SI; Moon HY Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661 [TBL] [Abstract][Full Text] [Related]
36. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer. Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer. Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315 [TBL] [Abstract][Full Text] [Related]
38. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity. Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434 [TBL] [Abstract][Full Text] [Related]
39. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer. Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237 [TBL] [Abstract][Full Text] [Related]
40. Nemo‑like kinase expression predicts poor survival in colorectal cancer. Chen J; Han Y; Zhao X; Yang M; Liu B; Xi X; Xu X; Liang T; Xia L Mol Med Rep; 2015 Feb; 11(2):1181-7. PubMed ID: 25371216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]